Advaxis

ADXS

3.04

+0.03

+1.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 3.05
Prev. Close: 3.01
Low/Hi: 2.98 - 3.06
52-Week: 2.71 - 10.06
Volumes
Equity: 448,824
90-Day Avg: 911,997
Option: 10
90-Day Avg: 135
Volatility
Todays Stock Vol: 30.7
20-Day (HV): 66.4
52-Week (HV): 62.0
30-Day IV: 65.5 -0.6
IV Pct Rank: 3% Subdued
Fundamental
Div. Yield:
Earnings: 22-Mar (Est.)
P/E Ratio:
Market Cap: 124.3 M
Short Int Pct: 0.0%
Pct Held By Inst.: 40.1%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ADXS Company Events

Upcoming Events
Event Event Date Location Info
No Upcoming Events
Past Events
Event Event Date Location Info
Cantor Fitzgerald Global Healthcare Conference Sep 25, 8:30 AM
International Cancer Immunotherapy Conference Sep 6, 2017 - Sep 9, 2017
2017 BIO International Convention Jun 20, 2017
Investor & Analyst Day Jun 12, 2017
Investor & Analyst Day Jun 12, 1:00 PM
Jefferies 2017 Global Healthcare Conference Jun 6, 2017 - Jun 9, 2017
2017 Barclays Global Healthcare Conference Mar 14, 2017
SGOs Annual Meeting on Womens Cancer Mar 12, 2017 - Mar 15, 2017
11th annual ImVacS-Immunization and Vaccine Summit Dec 9, 2016
Jefferies 2016 London Healthcare Conference Nov 17, 2016
Society for Immunotherapy of Cancers (SITC) 31st Annual Meeting & Associated Programs Nov 9, 2016 - Nov 13, 2016 Gaylord National Hotel & Convention Center in National Harbor, Md
Immune Profiling World Congress Oct 10, 2016 - Oct 12, 12:00 AM
i

Robert Petit, Ph.D., executive vice president and chief scientific officer of Advaxis, will speak

Aegis Capital Corporations 2016 Growth Sep 21, 2016 Encore at Wynn Las Vegas, Nev
Rodman & Renshaw Global Investment Conference Sep 12, 12:05 PM
Rodman & Renshaw 18th Annual Global Investment Conference Sep 11, 2016 - Sep 13, 2016
Cantor Fitzgerald Healthcare Conference Jul 13, 10:45 AM
Investor & Analyst Day Jun 28, 2016
Host Investor & Analyst Day Jun 28, 2016 New York, NY
Jefferies Healthcare Conference Jun 8, 2:30 PM
Jeffries 2016 Healthcare Conference Jun 7, 2016 - Jun 10, 2016 New York, NY
i

Daniel J. OConnor, President, Chief Executive Officer and Director of Advaxis, will present

American Society of Clinical Oncologys (ASCO) Annual Meeting Jun 3, 2016 - Jun 7, 2016 Chicago
i

the Companys immunotherapy agent will be featured in a poster presentation

American Association for Cancer Research (AACR) Annual Meeting Apr 18, 2016 Sheraton New Orleans Hotel in New Orleans, Louisiana
American Association for Cancer Research (AACR) Annual Meeting Apr 18, 2016 Sheraton New Orleans Hotel in New Orleans, Louisiana
American Association for Cancer Research (AACR) Annual Meeting. Apr 16, 2016 - Apr 20, 2016 Sheraton New Orleans Hotel in New Orleans, Louisiana.
i

An Update on ADXS-NEORobert Petit, PhD, Chief Scientific Officer, Advaxis

Barclays Global Healthcare Conference Mar 16, 2016 Loews Miami Beach Hotel in Miami Beach, Florida.
i

Daniel J. OConnor, President and Chief Executive Officer at Advaxis, will present

27th Annual ROTH Conference Mar 15, 2016
i

Gregory Mayes, Executive Vice President and Chief Operating Officer, will present

Advaxis Inc Annual Shareholders Meeting Mar 10, 2016
Cowens 36th Annual Health Care Conference Mar 9, 2016 Boston Marriott Copley Place
i

aniel J. OConnor, President and Chief Executive Officer, will present

2016 RBC Capital Markets Healthcare Conference Feb 23, 11:30 AM New York Palace in New York City
i

Daniel J. OConnor, president and chief executive officer, will present an overview of the companys business strategy and corporate programs . The presentation will provide an update on the Companys key milestones and initiatives for 2016 including its soon to be launched Phase 3 trial for axalimogene filolisbac for the treatment of high-risk locally advanced cervical cancer (AIM2CERV) and the launch of a Phase 2 trial in metastatic anal cancer (FAWCETT). The presentation will also review Advaxis advancing work in neo-epitopes through its partnership with Memorial Sloan Kettering Cancer Center and ongoing work in prostate cancer and with HER2-driven tumors.

JPMorgan Healthcare Conference Jan 11, 2016
2015 San Antonio Breast Cancer Symposium (SABCS) Dec 9, 2015 San Antonio, Texas
i

it will present a poster on Advaxiss Lm Technology cancer immunotherapy ADXS-HER2

Jefferies Autumn 2015 Global Healthcare Conference Nov 19, 2015 The May Fair Hotel in London
i

Daniel J. O'Connor, President and Chief Executive Officer of Advaxis, will discuss the Company's proprietary Lm Technology cancer immunotherapy platform, clinical programs and business strategy at 1:20 PM GMT.

2015 SITC Annual Meeting Nov 6, 2015 Gaylord National Hotel & Convention Center in National Harbor, Md
HPV Clinical Development Program Oct 6, 2015
10th Annual Wells Fargo Securities Healthcare Conference Sep 10, 2015 Boston, Mass.
World Congress on Breast Cancer 2015 Aug 4, 2015 Birmingham, UK.
Business Update Jun 25, 2015
3rd Annual Jefferies Immuno-Oncology Summit Boston Harbor Hotel

Wait, Before You Leave...

Want to Know More About ADXS Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon